• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
531752
INE703D01023
0.9409956
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
34
35.8
EPS(TTM)
Face Value()
Div & Yield %
0.01
1
0
 

spel semiconductor ltd
L G Balakrishnan & Bros consolidated net profit declines 17.03% in the March 2026 quarter
May 04,2026
Net profit of L G Balakrishnan & Bros declined 17.03% to Rs 69.73 crore in the quarter ended March 2026 as against Rs 84.04 crore during the previous quarter ended March 2025. Sales rose 21.79% to Rs 815.00 crore in the quarter ended March 2026 as against Rs 669.17 crore during the previous quarter ended March 2025.

For the full year,net profit rose 5.51% to Rs 318.75 crore in the year ended March 2026 as against Rs 302.11 crore during the previous year ended March 2025. Sales rose 19.29% to Rs 3075.63 crore in the year ended March 2026 as against Rs 2578.29 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales815.00669.17 22 3075.632578.29 19
OPM %14.1715.25 -15.7316.09 -
PBDT133.80114.10 17 537.07459.89 17
PBT102.2989.47 14 421.80368.36 15
NP69.7384.04 -17 318.75302.11 6